194 related articles for article (PubMed ID: 15046538)
1. How antidepressants help depression: mechanisms of action and clinical response.
Delgado PL
J Clin Psychiatry; 2004; 65 Suppl 4():25-30. PubMed ID: 15046538
[TBL] [Abstract][Full Text] [Related]
2. New approaches to antidepressant drug discovery: beyond monoamines.
Berton O; Nestler EJ
Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123
[TBL] [Abstract][Full Text] [Related]
3. History and evolution of the monoamine hypothesis of depression.
Hirschfeld RM
J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
[TBL] [Abstract][Full Text] [Related]
4. Can monoamine-based therapies be improved?
Demitrack MA
J Clin Psychiatry; 2002; 63 Suppl 2():14-8. PubMed ID: 15453009
[TBL] [Abstract][Full Text] [Related]
5. Models of antidepressant action.
Berman RM; Charney DS
J Clin Psychiatry; 1999; 60 Suppl 14():16-20; discussion 31-5. PubMed ID: 10408421
[TBL] [Abstract][Full Text] [Related]
6. Biological basis of depression and therapeutic relevance.
Richelson E
J Clin Psychiatry; 1991 Jun; 52 Suppl():4-10. PubMed ID: 1646793
[TBL] [Abstract][Full Text] [Related]
7. Does neurotropin-3 have a therapeutic implication in major depression?
Pae CU; Marks DM; Han C; Patkar AA; Steffens D
Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
[TBL] [Abstract][Full Text] [Related]
8. Depression: the case for a monoamine deficiency.
Delgado PL
J Clin Psychiatry; 2000; 61 Suppl 6():7-11. PubMed ID: 10775018
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute depression.
Richelson E
Psychiatr Clin North Am; 1993 Sep; 16(3):461-78. PubMed ID: 8415232
[TBL] [Abstract][Full Text] [Related]
10. [New options in the treatment of depression].
Frieling H; Hillemacher T; Demling JH; Kornhuber J; Bleich S
Fortschr Neurol Psychiatr; 2007 Nov; 75(11):641-52. PubMed ID: 17366379
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a biochemical lesion in depression.
Leonard BE
J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants and pain.
Micó JA; Ardid D; Berrocoso E; Eschalier A
Trends Pharmacol Sci; 2006 Jul; 27(7):348-54. PubMed ID: 16762426
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptides: relevance in treatment of depression and anxiety disorders.
Madaan V; Wilson DR
Drug News Perspect; 2009; 22(6):319-24. PubMed ID: 19771321
[TBL] [Abstract][Full Text] [Related]
14. The enhancement of social functioning as a therapeutic principle in the management of depression.
Healy D; McMonagle T
J Psychopharmacol; 1997; 11(4 Suppl):S25-31. PubMed ID: 9438230
[TBL] [Abstract][Full Text] [Related]
15. Treatment of mood disorders.
Nemeroff CB; Owens MJ
Nat Neurosci; 2002 Nov; 5 Suppl():1068-70. PubMed ID: 12403988
[TBL] [Abstract][Full Text] [Related]
16. The keys to improving depression outcomes.
Rizvi SJ; Kennedy SH
Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S694-702. PubMed ID: 21924209
[TBL] [Abstract][Full Text] [Related]
17. [Research progress on therapeutic mechanism of depression treated by traditional chinese medicine].
Mao QQ; Huang Z
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(10):877-80. PubMed ID: 17655134
[TBL] [Abstract][Full Text] [Related]
18. Relationship of neurotransmitters to the symptoms of major depressive disorder.
Nutt DJ
J Clin Psychiatry; 2008; 69 Suppl E1():4-7. PubMed ID: 18494537
[TBL] [Abstract][Full Text] [Related]
19. Beyond monoamine-based therapies: clues to new approaches.
Skolnick P
J Clin Psychiatry; 2002; 63 Suppl 2():19-23. PubMed ID: 15453010
[TBL] [Abstract][Full Text] [Related]
20. Monoamine specificity of antidepressants and prediction of therapeutic response.
Balon R
Encephale; 1991; 17 Spec No 1():121-2. PubMed ID: 1864258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]